Investors learned ofAmgenInc.’s$28 billion bidforHorizon TherapeuticsPLC in December. But a clue to a potential deal emerged months earlier, when insiders in the target company stopped selling stock....
Source LinkInvestors learned ofAmgenInc.’s$28 billion bidforHorizon TherapeuticsPLC in December. But a clue to a potential deal emerged months earlier, when insiders in the target company stopped selling stock....
Source Link
Comments